Neurona Therapeutics

About Neurona Therapeutics

Neurona Therapeutics is a clinical-stage biotherapeutics company developing regenerative neural cell therapies to repair dysfunctional neural circuits underlying chronic neurological disorders. The company focuses on allogeneic, off-the-shelf neural cell therapies, including neuronal, glial, and gene-edited candidates led by NRTX-1001, an inhibitory neuron therapy for epilepsy. Its therapies aim to permanently integrate into neural circuits to rebalance electrical activity and potentially provide long-lasting disease amelioration from a single treatment. Neurona is headquartered in South San Francisco, California.